Drug RecallsUPDATE: The FDA Reminds Patients and Health Care Providers of the Importance of At Least Yearly, Lifelong Follow-Up with Use of Endologix AFX Endovascular AAA Graft Systems: FDA Safety Communication Posted on by Editor Date: 01/13/2022 Product type: Medical Device USA-FDA Link: https://www.fda.gov/medical-devices/safety-communications/update-fda-reminds-patients-and-health-care-providers-importance-least-yearly-lifelong-follow-use Update on Risk of Type III Endoleaks with Use of Endologix AFX Endovascular AAA Graft Systems – FDA Safety Communication Buprenorphine: Drug Safety Communication – FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain
